England’s NICE Says No To Sanofi’s Dupixent For Asthma

 
• By Neena Brizmohun

The health technology assessment body does not believe Dupixent will be a cost-effective use of National Health Service resources.

Purse
NICE says the NHS should not fund Dupixent For Asthma • Source: Shutterstock

More from United Kingdom

More from Europe